Phase 2 Head and Neck Cancer Trial, Recruiting NCT04901234 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 2 Head and Neck Cancer Trial, Recruiting

NCT04901234
Recruiting Phase 2 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who are able to give written agreement to take part in the trial
  • People diagnosed with a specific stage of throat cancer (stage T3 or T4, with or without spread to nearby lymph nodes, as classified by a standard medical staging system)
  • People whose general health and ability to carry out daily activities falls within a certain range, as assessed by their doctor using a standard scale (confirm with trial site)
  • People who have had a tissue sample taken that confirmed a type of cancer called squamous cell carcinoma in the oropharynx (the middle part of the throat)
  • People whose treatment plan includes radiotherapy aimed at curing the cancer, with or without chemotherapy
  • Females of childbearing age who have had a negative pregnancy test
  • People who received chemotherapy before this trial and still have some remaining tumour present

Who may not be able to join:

  • People who have previously had radiation treatment to the head or neck area (though prior radiation for certain non-melanoma skin cancers may not apply — confirm with trial site)
  • People who have had surgery in the head or neck area, other than a small biopsy to diagnose the cancer
  • People who are pregnant or breastfeeding
  • People who have a connective tissue disease (a condition affecting the body's supporting tissues — confirm with trial site)
  • People who have a medical condition that, in the doctor's judgement, could prevent them from being monitored safely after radiotherapy
  • People who are unable to have an MRI scan for medical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Australian sites

Austin Health, Melbourne,

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Registry
ClinicalTrials.gov
Start date
30 July 2021
Est. completion
1 December 2024

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Patient-reported dysphagia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov